Document Detail

Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
MedLine Citation:
PMID:  16290985     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: In patients with acute myocardial infarction (MI), increased plasma glucose levels at hospital admission are associated with worse outcome. We aimed to assess the predictive value of admission glucose concentrations on short- and long-term mortality in patients with acute MI undergoing primary or rescue percutaneous coronary intervention (PCI). METHODS: We analyzed the 30-day and long-term (mean follow-up 3.7 years) outcome of 978 patients prospectively included in a single-center registry of patients with acute MI treated with PCI within 24 hours after onset of symptoms. Patients were classified according to plasma glucose levels at admission: < 7.8 mmol/L (group I, n = 322), 7.8 to 11 mmol/L (group II, n = 348), and > 11.0 mmol/L (group III, n = 308). RESULTS: Mortality at 30 days was 1.2% in group I, 6.3% in group II, and 16.6% in group III (P < .001). After multivariate adjustment for age, the presence of cardiogenic shock, and TIMI 3 flow after PCI, the association of mortality with glucose classification remained significant (P value for trend = .003). The relative risk of death at 30 days for group III versus group I was 3.9 (95% CI 1.2-13.2). During long-term follow-up, mortality was similar in groups I and II. However, in group III adjusted mortality remained significantly increased compared with group I (relative risk 1.76, CI 1.01-3.08). CONCLUSIONS: In patients undergoing emergency PCI for acute MI, glucose levels at hospital admission are predictive for short- and long-term survival. Knowledge of admission glucose levels may improve initial bedside risk stratification.
Edwin Straumann; David J Kurz; Jörg Muntwyler; Irene Stettler; Marcel Furrer; Barbara Naegeli; Jürgen Frielingsdorf; Ernst Schuiki; Raymond Mury; Osmund Bertel; Giatgen A Spinas
Related Documents :
11527615 - Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched compari...
11079655 - Methodological and clinical implications of the relocation of the minimal luminal diame...
25377505 - Intra-articular treatment with triamcinolone compared to triamcinolone with hyaluronate...
19717185 - Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction ...
12691505 - Improvement in clinical outcome by early nephrology referral in type ii diabetics on ma...
557865 - Lumbar sympathectomy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  150     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-18     Completed Date:  2005-12-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1000-6     Citation Subset:  AIM; IM    
Division of Cardiology, Department of Internal Medicine, Triemli Hospital, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Blood Glucose / analysis*
Follow-Up Studies
Middle Aged
Myocardial Infarction / blood,  mortality*,  therapy*
Patient Admission
Predictive Value of Tests
Prospective Studies
Time Factors
Reg. No./Substance:
0/Blood Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  &quot;Full metal jacket&quot; (stented length > or =64 mm) using drug-eluting stents for de novo cor...
Next Document:  Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiogra...